Cargando…
Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study
BACKGROUND: The prevalence of anxiety and depressive disorders in cancer patients and its associated factors in Pakistan is not known. There is a need to develop an evidence base to help introduce interventions as untreated depression and anxiety can lead to significant morbidity. We assessed the pr...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988751/ https://www.ncbi.nlm.nih.gov/pubmed/21034465 http://dx.doi.org/10.1186/1471-2407-10-594 |
_version_ | 1782192273530814464 |
---|---|
author | Jadoon, Nauman A Munir, Waqar Shahzad, Mohammad A Choudhry, Zeshan S |
author_facet | Jadoon, Nauman A Munir, Waqar Shahzad, Mohammad A Choudhry, Zeshan S |
author_sort | Jadoon, Nauman A |
collection | PubMed |
description | BACKGROUND: The prevalence of anxiety and depressive disorders in cancer patients and its associated factors in Pakistan is not known. There is a need to develop an evidence base to help introduce interventions as untreated depression and anxiety can lead to significant morbidity. We assessed the prevalence of depression and anxiety among adult outpatients with and without cancer as well as the effect of various demographic, clinical and behavioral factors on levels of depression and anxiety in cancer patients. METHODS: This cross-sectional study was carried out in outpatient departments of Multan Institute of Nuclear Medicine and Radiotherapy and Nishtar Medical College Hospital, Multan. Aga Khan University Anxiety and Depression Scale (AKUADS) was used to define the presence of depression and anxiety in study participants. The sample consisted of 150 diagnosed cancer patients and 268 participants without cancer (control group). RESULTS: The mean age of cancer patients was 40.85 years (SD = 16.46) and median illness duration was 5.5 months, while the mean age of the control group was 39.58 years (SD = 11.74). Overall, 66.0% of the cancer patients were found to have depression and anxiety using a cutoff score of 20 on AKUADS. Among the control group, 109 subjects (40.7%) had depression and anxiety. Cancer patients were significantly more likely to suffer from distress compared to the control group (OR = 2.83, 95% CI = 1.89-4.25, P = 0.0001). Performing logistic regression analysis showed that age up to 40 years significantly influenced the prevalence of depression and anxiety in cancer patients. There was no statistically significant difference between gender, marital status, locality, education, income, occupation, physical activity, smoking, cancer site, illness duration and mode of treatment, surgery related to cancer and presence of depression and anxiety. Cancers highly associated with depression and anxiety were gastrointestinal malignancies, chest tumors and breast cancer. CONCLUSIONS: This study highlights high prevalence rates of depression and anxiety in cancer patients. Younger age was associated with a higher likelihood of meeting criteria for psychological morbidity. The findings support screening patients for symptoms of depression and anxiety as part of standard cancer care and referring those at a higher risk of developing psychological morbidity for appropriate care. |
format | Text |
id | pubmed-2988751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29887512010-11-20 Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study Jadoon, Nauman A Munir, Waqar Shahzad, Mohammad A Choudhry, Zeshan S BMC Cancer Research Article BACKGROUND: The prevalence of anxiety and depressive disorders in cancer patients and its associated factors in Pakistan is not known. There is a need to develop an evidence base to help introduce interventions as untreated depression and anxiety can lead to significant morbidity. We assessed the prevalence of depression and anxiety among adult outpatients with and without cancer as well as the effect of various demographic, clinical and behavioral factors on levels of depression and anxiety in cancer patients. METHODS: This cross-sectional study was carried out in outpatient departments of Multan Institute of Nuclear Medicine and Radiotherapy and Nishtar Medical College Hospital, Multan. Aga Khan University Anxiety and Depression Scale (AKUADS) was used to define the presence of depression and anxiety in study participants. The sample consisted of 150 diagnosed cancer patients and 268 participants without cancer (control group). RESULTS: The mean age of cancer patients was 40.85 years (SD = 16.46) and median illness duration was 5.5 months, while the mean age of the control group was 39.58 years (SD = 11.74). Overall, 66.0% of the cancer patients were found to have depression and anxiety using a cutoff score of 20 on AKUADS. Among the control group, 109 subjects (40.7%) had depression and anxiety. Cancer patients were significantly more likely to suffer from distress compared to the control group (OR = 2.83, 95% CI = 1.89-4.25, P = 0.0001). Performing logistic regression analysis showed that age up to 40 years significantly influenced the prevalence of depression and anxiety in cancer patients. There was no statistically significant difference between gender, marital status, locality, education, income, occupation, physical activity, smoking, cancer site, illness duration and mode of treatment, surgery related to cancer and presence of depression and anxiety. Cancers highly associated with depression and anxiety were gastrointestinal malignancies, chest tumors and breast cancer. CONCLUSIONS: This study highlights high prevalence rates of depression and anxiety in cancer patients. Younger age was associated with a higher likelihood of meeting criteria for psychological morbidity. The findings support screening patients for symptoms of depression and anxiety as part of standard cancer care and referring those at a higher risk of developing psychological morbidity for appropriate care. BioMed Central 2010-10-29 /pmc/articles/PMC2988751/ /pubmed/21034465 http://dx.doi.org/10.1186/1471-2407-10-594 Text en Copyright ©2010 Jadoon et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Jadoon, Nauman A Munir, Waqar Shahzad, Mohammad A Choudhry, Zeshan S Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study |
title | Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study |
title_full | Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study |
title_fullStr | Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study |
title_full_unstemmed | Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study |
title_short | Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study |
title_sort | assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988751/ https://www.ncbi.nlm.nih.gov/pubmed/21034465 http://dx.doi.org/10.1186/1471-2407-10-594 |
work_keys_str_mv | AT jadoonnaumana assessmentofdepressionandanxietyinadultcanceroutpatientsacrosssectionalstudy AT munirwaqar assessmentofdepressionandanxietyinadultcanceroutpatientsacrosssectionalstudy AT shahzadmohammada assessmentofdepressionandanxietyinadultcanceroutpatientsacrosssectionalstudy AT choudhryzeshans assessmentofdepressionandanxietyinadultcanceroutpatientsacrosssectionalstudy |